E-viri
Recenzirano
Odprti dostop
-
Harris, Philip A; Faucher, Nicolas; George, Nicolas; Eidam, Patrick M; King, Bryan W; White, Gemma V; Anderson, Niall A; Bandyopadhyay, Deepak; Beal, Allison M; Beneton, Veronique; Berger, Scott B; Campobasso, Nino; Campos, Sebastien; Capriotti, Carol A; Cox, Julie A; Daugan, Alain; Donche, Frederic; Fouchet, Marie-Hélène; Finger, Joshua N; Geddes, Brad; Gough, Peter J; Grondin, Pascal; Hoffman, Bonnie L; Hoffman, Sandra J; Hutchinson, Susan E; Jeong, Jae U; Jigorel, Emilie; Lamoureux, Pauline; Leister, Lara K; Lich, John D; Mahajan, Mukesh K; Meslamani, Jamel; Mosley, Julie E; Nagilla, Rakesh; Nassau, Pamela M; Ng, Sze-Ling; Ouellette, Michael T; Pasikanti, Kishore K; Potvain, Florent; Reilly, Michael A; Rivera, Elizabeth J; Sautet, Stéphane; Schaeffer, Michelle C; Sehon, Clark A; Sun, Helen; Thorpe, James H; Totoritis, Rachel D; Ward, Paris; Wellaway, Natalie; Wisnoski, David D; Woolven, James M; Bertin, John; Marquis, Robert W
Journal of medicinal chemistry, 05/2019, Letnik: 62, Številka: 10Journal Article
RIP1 kinase regulates necroptosis and inflammation and may play an important role in contributing to a variety of human pathologies, including inflammatory and neurological diseases. Currently, RIP1 kinase inhibitors have advanced into early clinical trials for evaluation in inflammatory diseases such as psoriasis, rheumatoid arthritis, and ulcerative colitis and neurological diseases such as amyotrophic lateral sclerosis and Alzheimer’s disease. In this paper, we report on the design of potent and highly selective dihydropyrazole (DHP) RIP1 kinase inhibitors starting from a high-throughput screen and the lead-optimization of this series from a lead with minimal rat oral exposure to the identification of dihydropyrazole 77 with good pharmacokinetic profiles in multiple species. Additionally, we identified a potent murine RIP1 kinase inhibitor 76 as a valuable in vivo tool molecule suitable for evaluating the role of RIP1 kinase in chronic models of disease. DHP 76 showed efficacy in mouse models of both multiple sclerosis and human retinitis pigmentosa.
Avtor
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|
Vir: Osebne bibliografije
in: SICRIS
To gradivo vam je dostopno v celotnem besedilu. Če kljub temu želite naročiti gradivo, kliknite gumb Nadaljuj.